Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer. (nejm.org)

Authors: Tolaney SM … Schmid P Journal: New England Journal of Medicine Published: 2026-01-22 DOI: https://doi.org/10.1056/NEJMoa2508959